CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Medical Devices (6162) Pharma Startups (6570)
Exagen is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology and Autoimmune diseases. Committed to Personalized Medicine, ...Show all
Company (IPO / Went public)
Phone: +1 760 560 1501
1261 Liberty Way
Suite C
Vista, 92081
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Exagen | $156.1M | Sep 19, 2019 |
| Cellpoint Diagnostics | $0M | Nov 11, 2019 |
| See all 21 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Biomarkers for inflammatory bowel disease and irritable bowel syndrome | Mar 29, 2010 | Jul 24, 2012 | Patent |
| Biomarkers for inflammatory bowel disease and irritable bowel syndrome | Mar 29, 2010 | Jul 17, 2012 | Patent |
| Pharacogenetic method for prediction of the efficacy of methotrexate monotherapy in recent-onset arthritis | Aug 28, 2007 | Dec 06, 2011 | Patent |
| Biomarkers for inflammatory bowel disease and irritable bowel syndrome | Feb 23, 2010 | Apr 12, 2011 | Patent |
| Biomarkers for inflammatory bowel disease and irritable bowel syndrome | Mar 13, 2009 | Feb 01, 2011 | Patent |
